Thyme Care, a value-based oncology platform, has raised $60 million in a series B round.
The round was co-led by Town Hall Ventures and Foresite Capital with participation from existing investors Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital and Frist Cressey Ventures. The funding will be used to accelerate partnerships in new markets and expand its cancer care support services. Thyme Care also plans to broaden its roster of oncology and healthcare experts and announce additional partnerships in the coming months.
The latest capital brings the company’s total raised to more than $80 million.